Abbott India

Mumbai: In the week that wiped off Rs 4 lakh crore of market capitalisation on Dalal Street, investors still managed to make some money in the midcap and smallcap stocks. In the midcap…

, part of the pharma space, hit a fresh 52-week high in December 2022, but technical indicators suggest that the rally may not be over yet, suggest experts. Historical data suggests that the…

New Delhi: Domestic equity markets settled higher during the truncated week, thanks to upbeat economic data which boosted the morale of traders. Benchmark indices - BSE Sensex and Nifty50 -…

The US economy also witnessed substantial issues in its pharma market. In addition to these, manufacturing & exporting countries around the world saw heightened raw material price…

Nifty futures on the Singapore Exchange traded 13.5 points, or 0.08 per cent lower at 17,112, signaling that Dalal Street was headed for a negative start on Wednesday. Here are a dozen…

Abbott India Ltd shares have risen nearly 20% over the past five months, taking them above pre-covid levels. The rebound in the domestic pharma market’s growth is helping…